Works matching DE "EXTRANODAL NK-T-cell lymphoma"


Results: 106
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell Lymphomas.

    Published in:
    Cancers, 2023, v. 15, n. 10, p. 2743, doi. 10.3390/cancers15102743
    By:
    • Lucioni, Marco;
    • Fraticelli, Sara;
    • Santacroce, Giovanni;
    • Bonometti, Arturo;
    • Aronico, Nicola;
    • Sciarra, Roberta;
    • Lenti, Marco Vincenzo;
    • Bianchi, Paola Ilaria;
    • Neri, Giuseppe;
    • Feltri, Monica;
    • Neri, Benedetto;
    • Ferrario, Giuseppina;
    • Riboni, Roberta;
    • Corazza, Gino Roberto;
    • Vanoli, Alessandro;
    • Arcaini, Luca;
    • Paulli, Marco;
    • Di Sabatino, Antonio
    Publication type:
    Article
    11
    12
    13
    14
    15

    Targeting CD38 in Neoplasms and Non-Cancer Diseases.

    Published in:
    Cancers, 2022, v. 14, n. 17, p. 4169, doi. 10.3390/cancers14174169
    By:
    • Szlasa, Wojciech;
    • Czarny, Jakub;
    • Sauer, Natalia;
    • Rakoczy, Katarzyna;
    • Szymańska, Natalia;
    • Stecko, Jakub;
    • Kołodziej, Maksymilian;
    • Kaźmierczak, Maciej;
    • Barg, Ewa
    Publication type:
    Article
    16
    17
    18
    19
    20

    Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL).

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 12, p. 1914, doi. 10.1080/10428194.2023.2244101
    By:
    • Rajendra, Akhil;
    • Sengar, Manju;
    • Bonda, V.N. Avinash;
    • Jain, Hasmukh;
    • Nayak, Lingaraj;
    • Thorat, Jayashree;
    • Shet, Tanuja;
    • Epari, Sridhar;
    • Laskar, Siddharth;
    • Aggarwal, Archi;
    • Rangarajan, V.;
    • Gujral, Sumeet;
    • Bagal, Bhausaheb;
    • Kakoti, Sangeeta;
    • Salvi, Omkar
    Publication type:
    Article
    21

    Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2679, doi. 10.1080/10428194.2019.1599111
    By:
    • Qi, Fei;
    • Chen, Bo;
    • Wang, Jingjing;
    • Lin, Xinyi;
    • Qi, Shunan;
    • Yang, Jianliang;
    • Zhou, Shengyu;
    • Wang, Shulian;
    • Gui, Lin;
    • Fang, Hui;
    • Liu, Peng;
    • Song, Yongwen;
    • Yang, Sheng;
    • Li, Yexiong;
    • Dong, Mei
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study.

    Published in:
    Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01020-y
    By:
    • Huang, Huiqiang;
    • Zhu, Jun;
    • Yao, Ming;
    • Kim, Tae Min;
    • Yoon, Dok Hyun;
    • Cho, Seok-Goo;
    • Eom, Hyeon Seok;
    • Lim, Soon Thye;
    • Yeh, Su-peng;
    • Song, Yuqin;
    • Kwong, Yok Lam;
    • Kim, Jin Seok;
    • Jin, Jie;
    • Shi, Yuankai;
    • Kim, HyeJin;
    • Qing, Min;
    • Zhou, Tianyuan;
    • Gao, Grace;
    • Dong, Zongqi;
    • Qi, Ming
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    PUBLICATION.

    Published in:
    Hematological Oncology, 2021, v. 39, p. 384, doi. 10.1002/hon.2881
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50